Physician profile
Ankit Patel
NPI 1831535350
$8,239.88
in general payments reported to CMS, 2019-2025
22 companies · $639 in 2025
The $639 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,665 · 2020: $1,945 · 2021: $941 · 2022: $909 · 2023: $1,239 · 2024: $901 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,778.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,618.49 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,225.62 | 2019-2025 | Na |
| Vertiflex, INC. | $1,161.74 | 2019 | |
| Nevro Corp. | $1,158.90 | 2019-2024 | Senza |
| Medtronic, INC. | $744.27 | 2022-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Saluda Medical Americas, INC. | $291.65 | 2024-2025 | Evoke |
| Spinal Simplicity, LLC | $198.38 | 2024-2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $169.12 | 2025 | Senza, Omnia |
| Stryker Corporation | $146.43 | 2025 | Mild Device Kit, Multigen 2 |
| Medtronic USA, INC. | $91.35 | 2019-2020 | |
| Painteq LLC | $90.73 | 2023-2024 | Painteq |
| Spr Therapeutics, INC | $62.00 | 2019-2023 | Sprint Pns System |
| Fidia Pharma USA INC. | $55.13 | 2022 | |
| Nalu Medical, INC. | $48.78 | 2025 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $30.68 | 2024 | Qutenza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $29.36 | 2024 | |
| Pfizer INC. | $27.80 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $22.70 | 2019 | |
| Daiichi Sankyo INC. | $21.31 | 2019 | |
| Medline Industries Lp | $16.48 | 2024 | |
| International Rehabilitative Sciences, INC | $14.78 | 2024 | Rs 4i Plus Sequential Stimulator |
| Biodelivery Sciences International, INC. | $14.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.